COPD Patients Need More Education on Wildfire Smoke Risks
New research suggests COPD patients lack critical information and clinical guidance to manage respiratory risks during wildfire events.
New research suggests COPD patients lack critical information and clinical guidance to manage respiratory risks during wildfire events.
A 10-year study in sub-Saharan Africa revealed that a higher dose of the oral medication Hydroxyurea improved survival and growth outcomes in children with sickle cell anemia.
Phase 3 clinical trial data shows improvements in walking distance and duration for patients with autoimmune pulmonary alveolar proteinosis treated with inhaled molgramostim.
A large-scale mold intervention in New York City public housing resulted in nearly 2,800 fewer annual asthma-related emergency department visits.
A newly discovered biological process protects liver cells from protein buildup in patients with alpha-1-antitrypsin deficiency.
New research indicates that baseline lung health is a stronger predictor of SARS-CoV-2 outcomes in cystic fibrosis transplantation patients than the time elapsed since transplantation.
Data from clinical trials investigating treatments for pulmonary hypertension and pulmonary fibrosis will be highlighted at ATS 2026.
New studies suggest that airway and breathing failures are the primary causes of death in childhood food anaphylaxis, requiring a shift in emergency management protocols.
Benralizumab (Fasenra) is now indicated to reduce the risk of flare ups for adult and pediatric patients with hypereosinophilic syndrome.